We validated our newly developed RNA-seq–based ER test (rsERT) in a retrospective cohort study including 511 PGT cycles and reported experience in treating an infertile female patient complicated by multiple endocrine neoplasia type 1 (MEN1). Here, MEN1 is linked to Infertility.